日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Real-World Analysis of Initial Clinical Response and Future Outcomes Among Patients with Rheumatoid Arthritis Initiating and Remaining on a First-Line Tumor Necrosis Factor Inhibitor in the United States

美国接受一线肿瘤坏死因子抑制剂治疗的类风湿性关节炎患者的初始临床反应和未来结局的真实世界分析

Charles-Schoeman, Christina; Zueger, Patrick; McDearmon-Blondell, Erin; Fang, Siran; Peng, Yi; Oishi, Tanjinatus; Jain, Manish; Tesser, John

Simplified meal announcement study (SMASH) using hybrid closed-loop insulin delivery in youth and young adults with type 1 diabetes: a randomised controlled two-centre crossover trial

一项针对 1 型糖尿病青少年和青年患者的简化膳食通知研究 (SMASH),采用混合闭环胰岛素输注系统:一项随机对照双中心交叉试验

Laesser, Céline I; Piazza, Camillo; Schorno, Nina; Nick, Fabian; Kastrati, Lum; Zueger, Thomas; Barnard-Kelly, Katharine; Wilinska, Malgorzata E; Nakas, Christos T; Hovorka, Roman; Herzig, David; Konrad, Daniel; Bally, Lia

Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial

每周一次 IcoSema 与每周一次 semaglutide 治疗 2 型糖尿病成人患者的疗效比较:COMBINE 2 随机临床试验

Lingvay, Ildiko; Benamar, Malik; Chen, Liming; Fu, Ariel; Jódar, Esteban; Nishida, Tomoyuki; Riveline, Jean-Pierre; Yabe, Daisuke; Zueger, Thomas; Réa, Rosângela

Correction: Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial

更正:每周一次 IcoSema 与每周一次 semaglutide 在 2 型糖尿病成人患者中的比较:COMBINE 2 随机临床试验

Lingvay, Ildiko; Benamar, Malik; Chen, Liming; Fu, Ariel; Jódar, Esteban; Nishida, Tomoyuki; Riveline, Jean-Pierre; Yabe, Daisuke; Zueger, Thomas; Réa, Rosângela

One Size Does Not Fit All: The Need for Sex-Specific Precision Medicine in Diabetes Technology

一刀切的方案并不适用:糖尿病技术领域需要针对不同性别的精准医疗

Hossmann, Stefanie; Tan, Susanne; Mader, Julia K; Klonoff, David C; Adams, Dawn; Ballhausen, Hanne; Bally, Lia; Balmer, Maria L; Braunack-Mayer, Vincent; Bonhoure, Anne; Burren, David; Boughton, Charlotte K; Cengiz, Deniz; Eberle, Claudia; Fabris, Chiara; Friedman, Maya; Fröhlich-Reiterer, Elke; Gunn, Tim; Gusyatiner, Olga; Hastings, Theresa; Huwiler, Valentina V; Khan-Gallo, Saira; Levy, Carol J; Moser, Othmar; O'Kane, Aisling Ann; Keighron, Cameron; Oliver, Nick; Prioleau, Temiloluwa; Thybo, Tanja; Yardley, Jane; Zueger, Thomas; Faber-Heinemann, Gabriele; Heinemann, Lutz; Rothenbühler, Martina

Health Disparities in Rheumatology in the United States

美国风湿病学领域的健康差异

Wright, Grace C; Zueger, Patrick M; Copley-Merriman, Catherine; Khan, Shahnaz; Costello, Jessica; Krumbach, Alisha; Reddy, Priya; Tanjinatus, Oishi; Wells, Alvin F

Measuring financial distress in German cancer patients: development and validation of the Financial Distress of Cancer Assessment Tool (FIAT)

衡量德国癌症患者的经济困境:癌症患者经济困境评估工具(FIAT)的开发与验证

Richter, L; Pauge, S; Mehlis, K; Zueger, A; Surmann, B; Mathies, V; Greiner, W; Ernst, T; Winkler, E C; Menold, N

mRNA Display Identifies Potent, Paralog-Selective Peptidic Ligands for ARID1B

mRNA 显示可识别 ARID1B 的有效、旁系同源选择性肽配体

Gregor S Cremosnik, Yannick Mesrouze, Patrik Zueger, David Furkert, Frédéric Grandjean, Dayana Argoti, Fanny Mermet-Meillon, Matthias R Bauer, Scott Brittain, Phuong Rogemoser, Winnie Yang, Jerome Giovannoni, Lynn McGregor, Jenny Tang, Mark Knapp, Sandra Holzinger, Sylvia Buhr, Lionel Muller, Lukas

Real-World Use and Effectiveness Outcomes in Patients with Rheumatoid Arthritis Treated with Upadacitinib: An Analysis from the CorEvitas Registry

Upadacitinib治疗类风湿性关节炎患者的真实世界应用及疗效结果:来自CorEvitas注册研究的分析

Baker, Joshua F; Zueger, Patrick; Ali, Mira; Bennett, Denise; Yu, Miao; Munoz Maldonado, Yolanda; McLean, Robert R

Real-World Treatment and Care Patterns in Patients With Rheumatoid Arthritis Initiating First-Line Tumor Necrosis Factor Inhibitor Therapy in the United States

美国接受一线肿瘤坏死因子抑制剂治疗的类风湿性关节炎患者的真实世界治疗和护理模式

Edgerton, Colin; Frick, Andrew; Helfgott, Simon; Huston, Kent Kwas; Singh, Jasvinder A; Zueger, Patrick; Anyanwu, Samuel I; Patel, Pankaj; Soloman, Nehad